Literature and links
Prof. Agostoni PG et al.: Long-term use of k-strophanthin in advanced congestive heart failure due to dilated cardiomyopathy: a douple-blind crossover evaluation versus digoxin. Clinical Cardiology 17: 536-541, 1994
On the homepage of Rolf Petry you will find lots of information about Ouabain in English.
Here you will find a lot of support for the myogenic cause
of heart failure, Angina pectoris and heart infarction. http://www.infarctcombat.org
Prof. Giorgio Baroldi: u. Malcoml D. Silver: The Etiopathogenesis of Coronary Heart Disease: A Heretical Theory Based on Morphology. Dies ist das Lebenswerk des mailänder Herzspezialisten und Anatoms Prof. Baroldi. Er beweist darin, dass auch andere Ursachen in Betracht kommen können als die übliche Vorstellung der Einengung der Koronararterien.
A very good description from Canada by Lyra Nara from Dr. Christine Siepe.
Dr. Fuerstenwerth: Rethinking
Heart Failure
Dr. Fuerstenwerth: “Ouabain, the insulin of the heart”.
Dr. Fuerstenwerth: PubMed Abstract
Dr. Fuerstenwerth: “On the Diffrenences Between Ouabain and Digitalis Glycosides”.
Dr. Fuerstenwerth: Ouabain – a gift from paradise
Video by
Dr. Fuerstenwerth regarding his project “Cornavita” with best
arguments for Strophanthin (Oubain)
Prof. Hamlyn JM et al.: Identification and characterization of a ouabain-like compound from human plasma. Proceedings of the National Academy of Sciences of the USA 88: 259, 1991
Prof. D’Urso: Cardioprotection by ouabain and digoxin in perfused rat hearts.
Bauer Natali, Jochen Müller-Ehmsen, Ulrike Krämer, Njde Hambarchian, Carsten Zobel, H.G.Schwinger, Horst Neu, Ulrike Kirch, Ernst-Günther Grünbaum & Wilhelm Schoner (Giessen): Ouabain-like compound changes rapidly on physical exercise in humans and dogs. Hypertension 45: 1024-28, 2005
Gao J et al.: Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides. Journal of General Physiology 119: 297-312, 2002
Clausen: Acute Stimulation of Na/K Pump by Cardiac Glycosides in Nanomolar Range
Marchetti GV et al.: Blood levels and tissue distribution of 3H-ouabain administered per os. Arzneimittelforschung 21: 1399-1403, 1971
Marzo A, Ghirardi P & Marchetti G: The absorption, distribution and excretion of k-strophantoside-H in guinea pigs after parenteral administration. Journal of Pharmacology and Experimental Therapy 189: 185-193, 1974
Leuschner J & Winkler A: Toxicological studies with ouabain. Naunyn-Schmiedeberg´s Archives of Pharmacology 363 (4) Suppl.: 139, abstract 544, 2001
Kitano S et al.: Exogenous Ouabain is accumulated in the adrenals and mimics the kinetics of endogenous digitalis-like-factor in rats. Hypertension Research 21: 47-56, 1998
Greenberger NJ et al.: Intestinal absorption of six tritium-labeled digitalis glycosides in rats and guinea pigs. Journal of Pharmacology and Experimental Therapy 167: 265-273, 1969
Aperia, Anita: 2011 Homer Smith Award: To serve and protect: Classic and novel roles for Na+K+ Adenosine Triphosphatase.
A really good and competent Article from Jeffrey Dach MD, Florida : https://jeffreydachmd.com/2014/08/preventing-heart-attacks-ouabain/
Article: what causes heart attacks
Dr. Cowan has written an new book on heart disease treatement, especially by Ouabain (Strophanthine). He was intrviewt by Dr. Mercola and an article postet on mercola.com on December 18, 2016. Homepage: https://fourfoldhealing.com/
Here the link to a video on you tube: Cause and Prevention of Heart Attacks. A speech from Thomas Cowan, given at the Freedom Law School in California 2009.
http://www.westonaprice.org/author/tcowan/
Heartening stories of patients regarding Strophanthin, sent by Dr. Cowan
Sroka: Artikel im Journal of Cardiology and Clinical Practive aus 2020.
OUABAIN – A Drug for Treatment of COVID-19
HRV Task Force of The European Society of Cardiology
J. Thomas Bigger: RR Varability to Predict Mortality After Myocardial Infarction
Dr. Fürstenwerth: On the Differences Between Ouabain and Digitalis Glycosides.
PubMed Abstract
Dr. Fürstenwerth: “Ouabain, the insulin of the heart”.
Dr. Fürstenwerth: Ouabain, the key to cardioprotections. Erschienen im Am.J.Ther. 2014 Sept-Okt 21 (5): 395-402
Dr. Fürstenwerth: Ouabain and Endogenous ouabain – Dr. Jekyll and Mr. Hyde of Cardiac Glycosides? British Journal of Medicine & Medical Research 8 (5): 477-484, 2015. Article no. BJMMR.2015.470.
Dr. Fürstenwerth: Rethinking heartfailure
Lichtstein, David u.a: Reduction in maternal circulating Ouabain impairs offspring growth and kidney development. 2014 by the American Society of Nephrology.
Lichtstein, David: Experimantal study: Augmentation of Ouabain-Induced Increase in Heart Muscle Contractility by Akt
Inhibitor MK-2206
Cardiac Infarction by Dr. Rainer Moser.
R.-J. Petry Ouabain
http://www.teebrasil.com/index.php?id_product=486…
Ouabain (g-Strophanthin) “Milk for the ageing heart”. Article by Dr. A. Kracke, Naturopath. Semmelweis-Institut, Verlag für Naturheilkunde Germany. 69/2004.
file:///C:/Users/debus/Downloads/Ouabain_Milk_for_the_ageing_heart.pdf
Nesher, Lichtstein: Ouabain attenuates cardiotoxicity induced by other cardiac steroids
Lichtstein: Identification of digitalis‐like compounds (= Strophanthin !) in human cataractous lenses – European Journal of Biochemistry
Here you will have the article of A.G. McKenzie, file:///C:/Users/debus/Downloads/The_rise_and_fall_of_Strophanthin.pdf
former anästhesist. He like many other doctors can not understand that Strophanthin has fallen, because it is was so good in helping to get safety for operations.
The best homepage regarding heart attack and Strophanthin is that of Dr. Knut Sroka. It is so good, it could even be helpful for doctors! His main therapie-tool for heart deseases is Ouabain. He explains it in the menupoint FAQ, there point number 10.
De Mesquita, Quintiliano H., u.a.: The Infarct Combat Project